1. Aburatani H, Matsumoto A, Kodama T, Takaku F, Fukazawa C, Itakura H (1988) Increased levels of messenger ribonucleic acid for apolipoprotein E in the spleen of probucol-treated rabbits. Am J Cardiol 62: 60B - 65B
2. Agellon LB, Walsh A, Hayek T, Moulin P, Jiang XC, Shelanski SA, Breslow JL, Tall AR (1991) Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 266: 10796–10801
3. Alexandre A, Doni MG, Padoin E, Deana R (1986) Inhibition by antioxidants of agonist evoked cytosolic Ca++ increase, ATP secretion and aggregation of aspirinated human platelets. Biochem Biophys Res commun 139: 509–514
4. Anastasi A, Betteridge DJ, Galton DJ (1980) Effect of probucol and other drugs on sterol synthesis in human lymphocytes. In: Noseda G, Lewis B, Paoletti R (eds) Diet and drugs in atherosclerosis. Raven, New York, pp 161–163
5. Arnold JA, Martin D, Taylor HL, Christian DR, Heeg JF (1970) Absorption and excretion studies of the hypocholesterolemic agent 4,4’-(isopropylidenedithio) bis(2,6-di-t-butylphenol) (DH-581) in man. Fed Proc 29: 622